CINCINNATI--(BUSINESS WIRE)--Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2017 annual shareholders’ meeting. Each of the directors continues from the prior term.
Shareholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2017. Shareholders also approved Chemed’s executive compensation and recommended an advisory vote be conducted annually.
Dividend Declared
Following the shareholders’ meeting, Chemed’s Board of Directors declared a quarterly cash dividend of 26 cents per share on the Company’s capital stock, payable on June 14, 2017, to shareholders of record as of May 25, 2017. This represents the 184th consecutive quarterly dividend paid to shareholders in Chemed’s 46 years as a public company.
The shareholder’s meeting presentation can be accessed through the Chemed website at www.chemed.com (Investor Relations).
Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hospice care, and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
